Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4217944
Max Phase: Preclinical
Molecular Formula: C14H16FN3O3S
Molecular Weight: 325.36
Molecule Type: Small molecule
Associated Items:
ID: ALA4217944
Max Phase: Preclinical
Molecular Formula: C14H16FN3O3S
Molecular Weight: 325.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1cc(OCCNCc2ccc(S(=O)(=O)F)cc2)ccn1
Standard InChI: InChI=1S/C14H16FN3O3S/c15-22(19,20)13-3-1-11(2-4-13)10-17-7-8-21-12-5-6-18-14(16)9-12/h1-6,9,17H,7-8,10H2,(H2,16,18)
Standard InChI Key: OJWQOESXUVIZMC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 325.36 | Molecular Weight (Monoisotopic): 325.0896 | AlogP: 1.49 | #Rotatable Bonds: 7 |
Polar Surface Area: 94.31 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.53 | CX LogP: 1.38 | CX LogD: -0.27 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.59 | Np Likeness Score: -0.30 |
1. Jiao GS, Kim S, Moayeri M, Thai A, Cregar-Hernandez L, McKasson L, O'Malley S, Leppla SH, Johnson AT.. (2018) Small molecule inhibitors of anthrax edema factor., 28 (2): [PMID:29198864] [10.1016/j.bmcl.2017.11.040] |
Source(1):